Alterity Therapeutics Limited (ATHE)

Alterity Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	49.2	33.16	12.64	15.77	34.81	28.12
Cash & Short-Term Investments	49.2	33.16	12.64	15.77	34.81	28.12
Cash Growth	984.53%	162.35%	-19.87%	-54.68%	23.80%	205.71%
Accounts Receivable	6.84	3.94	4.04	8.67	4.73	4.28
Other Current Assets	0.78	8.77	2.36	2.61	1.61	1.1
Total Current Assets	56.82	45.87	19.04	27.05	41.14	33.49
Net Property, Plant & Equipment	0.1	0.16	0.19	0.27	0.22	0.1
Total Assets	56.92	46.03	19.22	27.32	41.36	33.59
Accounts Payable	1.6	2.58	4.62	3.52	5.08	2.5
Accrued Expenses	0.94	0.88	0.53	0.73	0.66	0.54
Current Portion of Leases	0.03	0.07	0.11	0.11	0.06	0.03
Other Current Liabilities	0.02	0.02	0.12	0.03	0.03	-
Total Current Liabilities	2.59	3.53	5.37	4.38	5.82	3.07
Long-Term Leases	0.07	0.09	0.05	0.1	0.06	0.04
Other Long-Term Liabilities	-	-	-	0.02	0.01	0.01
Total Long-Term Liabilities	0.07	0.09	0.05	0.12	0.07	0.05
Total Liabilities	2.65	3.62	5.43	4.5	5.89	3.12
Common Stock	282.51	262.95	223.15	213.97	213.79	197.45
Additional Paid-in Capital	6.13	5.34	4.81	3.97	3.57	2.75
Retained Earnings	-234.38	-225.89	-214.16	-195.13	-181.88	-169.73
Shareholders' Equity	54.27	42.4	13.8	22.81	35.47	30.47
Total Liabilities & Equity	56.92	46.03	19.22	27.32	41.36	33.59
Total Debt	0.1	0.16	0.16	0.21	0.12	0.07
Net Cash (Debt)	49.1	33	12.48	15.56	34.69	28.05
Net Cash Growth	48.78%	164.45%	-19.81%	-55.13%	23.67%	206.12%
Net Cash Per Share	3.34	3.10	2.05	3.85	8.65	9.92
Book Value	54.27	42.4	13.8	22.81	35.47	30.47
Book Value Per Share	3.69	3.98	2.27	5.64	8.85	10.77
Tangible Book Value	54.27	42.4	13.8	22.81	35.47	30.47
Tangible Book Value Per Share	3.69	3.98	2.27	5.64	8.85	10.77

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q